Mavik and Gait disturbance - a phase IV clinical study of FDA data

Summary:

Gait disturbance is reported as a side effect among people who take Mavik (trandolapril), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Cosentyx, and have Pain.

The phase IV clinical study analyzes which people have Gait disturbance when taking Mavik. It is created by eHealthMe based on reports of 3,071 people who have side effects when taking Mavik from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Gait disturbance?

Gait disturbance is found to be associated with 2,809 drugs and 3,668 conditions by eHealthMe. Check the latest studies of Gait disturbance.

On Jul, 26, 2026

3,071 people reported to have side effects when taking Mavik.
Among them, 87 people (2.83%) have Gait disturbance.

Among these 87 people:

How long have people been on Mavik when they have Gait disturbance? *

What is the gender of people who have Gait disturbance when taking Mavik? *

female: 45.24 %
male: 54.76 %

What is the age of people who have Gait disturbance when taking Mavik? *

What are other drugs people take besides Mavik? *

What are other side effects people have besides Gait disturbance? *

Weakness: 52 people, 59.77%
Joint Pain: 50 people, 57.47%
Pain In Extremity: 47 people, 54.02%
Fatigue (feeling of tiredness): 41 people, 47.13%
Pain: 33 people, 37.93%
Diarrhea: 32 people, 36.78%
Back Pain: 30 people, 34.48%
Head Injury: 30 people, 34.48%
Malaise (a feeling of general discomfort or uneasiness): 30 people, 34.48%
Productive Cough: 26 people, 29.89%

What are the existing conditions these people have? *

Pain: 33 people, 37.93%
Depression: 25 people, 28.74%
High Blood Cholesterol: 23 people, 26.44%
Ankylosing Spondylitis (type of arthritis affecting the spine): 20 people, 22.99%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 6.90%
Metastatic Carcinoid Tumor: 6 people, 6.90%
Urine Flow Decreased: 6 people, 6.90%
Diabetes: 4 people, 4.60%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 3.45%
Insomnia (sleeplessness): 3 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and have Gait disturbance?

- Check whether Gait disturbance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mavik:

Mavik (3,145 reports)

Gait disturbance treatments and more:

Gait disturbance (245,673 reports)

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gait disturbance:

Gait disturbance (2,809 drugs)

Browse all the conditions that are associated with Gait disturbance:

Gait disturbance (3,668 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril (the active ingredients of Mavik) and Mavik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.